Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tianjin Medical University Cancer Institute and Hospital
1. Phase II/III study,
2. Randomized, multicenter, open-label study,
3. Evaluated the effects of chemotherapy combination with autologous cytokine-induced killer Cell immunotherapy compared with chemotherapy in patients with stage IIIb-IV squamous non-small-cell lung cancer
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Sex: male or female
Age: from 18 to 80 years
Histology: squamous non-small-cell lung cancer
Clinical stage: from stage IIIb to stage IV
Therapy: not received chemotherapy, radiotherapy, or immunotherapy before entry into this study
Karnofsky performance status: more than 50%
Expected survival: more than 2 months
Laboratory tests results 7 days before the start of treatment:
White blood cells: more than 3.0 × 109/L Platelets: more than 100 × 109/L Neutrophils: more than 1.5 × 109/L Hemoglobin: more than 80g/L Serum glutamate pyruvate transaminase: less than 2.5 folds of the upper normal limit (ULN) Serum glutamic-oxal (o) acetic transaminase: less than 2.5 × ULN Serum bilirubin: less than 1.25 × ULN Serum creatinine: less than 1.25 × ULN
pregnancy test: the test of women of child-bearing period must be negative 7 days before the start of treatment
Contraception: male and female subjects of child-bearing period must adopt a reliable method of contraception before entry into this study until 30 days after stopping this study
Informed consent: subject must have the ability to understand and voluntarily sign a written informed consent
You may not be if
History of neoplasms: other neoplasms
Medical history: mental disease, or congestive heart failure, or severe coronary artery disease, or cardiac arrhythmias, or concomitant corticosteroid therapy
History of allergies: allergic to the study drugs
Metastasis: clinical symptoms of brain metastasis
Other clinical trial: the subject received other clinical trial before this study
Laboratory tests: the serum test of human immunodeficiency virus, or hepatitis B virus, or hepatitis C virus was positive
Woman: pregnant or lactating women
Compliance: poor compliance
History of neoplasms: other neoplasms
Clareo Health | Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer
